Company No: 08349399 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Statement of Changes in Equity
• Notes to the Abridged Financial Statements

DIRECTORS	Emma Beckley
	Clive Graeme Bramley
	John Eric Clarkson
	John Samuel Matthews

REGISTERED OFFICE	34 High Street
	Aldridge
	Walsall
	WS9 8LZ
	United Kingdom

COMPANY NUMBER

08349399 (England and Wales)

CHARTERED ACCOUNTANTS	Edwards Chartered Accountants
	34 High Street
	Aldridge
	Walsall
	WS9 8LZ

	Note	2025		2024
		£		£
Fixed assets
Intangible assets	5	306,497		294,688
Tangible assets	6	5,462		6,427
		311,959		301,115
Current assets
Stocks		1,000		1,000
Debtors		28,116		29,295
Cash at bank and in hand		914		6,100
		30,030		36,395
Creditors: amounts falling due within one year		( 41,588)		( 18,676)
Net current (liabilities)/assets		(11,558)		17,719
Total assets less current liabilities		300,401		318,834
Creditors: amounts falling due after more than one year		( 417)		( 7,615)
Net assets		299,984		311,219
Capital and reserves
Called-up share capital	7	1,411		1,411
Share premium account		483,969		483,969
Other reserves		11,369		11,369
Profit and loss account		( 196,765 )		( 185,530 )
Total shareholders' funds		299,984		311,219

For the financial year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered,
• All of the members of Heimdall Protective Tech Ltd have consented to the preparation of the abridged financial statements for the financial year ended 31 January 2025 in accordance with Section 444(2A) of the Companies Act 2006.

The financial statements of Heimdall Protective Tech Ltd (registered number: 08349399) were approved and authorised for issue by the Board of Directors on 16 October 2025. They were signed on its behalf by:

Emma Beckley Director

	Called-up share capital		Share premium account		Other reserves		Profit and loss account		Total
	£		£		£		£		£
At 01 February 2023	931		435,765		13,100		( 178,829)		270,967
Loss for the financial year	0		0		0		( 8,432)		( 8,432)
Total comprehensive loss	0		0		0		( 8,432)		( 8,432)
Issue of share capital	480		48,204		0		0		48,684
Credit to equity for equity settled share-based payment	0		0		( 1,731)		1,731		0
At 31 January 2024	1,411		483,969		11,369		( 185,530)		311,219
At 01 February 2024	1,411		483,969		11,369		( 185,530)		311,219
Loss for the financial year	0		0		0		( 11,235)		( 11,235)
Total comprehensive loss	0		0		0		( 11,235)		( 11,235)
At 31 January 2025	1,411		483,969		11,369		( 196,765)		299,984

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Heimdall Protective Tech Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 34 High Street, Aldridge, Walsall, WS9 8LZ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Share-based payment

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black-Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Development costs	7 years straight line
Trademarks, patents and licences	5 years straight line

Research and development

Development costs have not been amortised during this financial year as the company did not start to receive economic benefit from the intellectual property until after the balance sheet date.

Trademarks, patents and licences

Separately acquired patents and trademarks are included at cost and amortised in equal annual instalments over a period of 5 years which is their estimated useful economic life. Provision is made for any impairment.

Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives as follows:

Plant and machinery	5 - 12.5 years straight line
Office equipment	3 years straight line
Computer equipment	3 years straight line

Impairment of assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and bank only.

Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include trade debtors, other debtors, and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities, including trade creditors, bank loans, taxation and social security, and other creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of fixed assets.

Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2. Critical accounting judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the company during the year, including directors	1		1

4. Share-based payments

Equity-settled share-based payment schemes

The options outstanding at 31 January 2025 had an exercise price of £0.01, and a remaining contractual life of 6.07 years.

Details of the share options outstanding during the financial year are as follows:

	2025			2024
	Weighted Average			Weighted Average
	Number of share options	Average exercise price (£)		Number of share options	Average exercise price (£)
Outstanding at beginning of period	2,278	0.01		2,878	1.05
Expired during the period	0	0		( 600)	1.05
Outstanding at the end of the period	2,278	0.01		2,278	0.01
Exercisable at the end of the period	2,278	0.01		2,278	0.01

The fair value of the share options at the grant date was calculated using the Black Scholes model, which is considered to be the most appropriate generally accepted valuation method of measuring fair value.

During the year, the company recognised a credit of £Nil (2024: £1,731) which relates to equity settled share based payment transactions. This is recognised as a transfer between reserves.

5. Intangible assets

	Development costs		Trademarks, patents and licences		Total
	£		£		£
Cost
At 01 February 2024	294,688		23,554		318,242
Additions	11,809		0		11,809
At 31 January 2025	306,497		23,554		330,051
Accumulated amortisation
At 01 February 2024	0		23,554		23,554
At 31 January 2025	0		23,554		23,554
Net book value
At 31 January 2025	306,497		0		306,497
At 31 January 2024	294,688		0		294,688

6. Tangible assets

	Plant and machinery		Office equipment		Computer equipment		Total
	£		£		£		£
Cost
At 01 February 2024	15,319		2,136		1,004		18,459
Disposals	0		( 1,378)		0		( 1,378)
At 31 January 2025	15,319		758		1,004		17,081
Accumulated depreciation
At 01 February 2024	8,912		2,116		1,004		12,032
Charge for the financial year	945		20		0		965
Disposals	0		( 1,378)		0		( 1,378)
At 31 January 2025	9,857		758		1,004		11,619
Net book value
At 31 January 2025	5,462		0		0		5,462
At 31 January 2024	6,407		20		0		6,427

7. Called-up share capital

	2025		2024
	£		£
Allotted, called-up and fully-paid
141,103 Class 1 ordinary shares of £ 0.01 each	1,411		1,411